DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Donitriptan
Donitriptan
Diapositiva 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Screening of Clinically Approved and Investigation
Genetic Risk Prediction and Neurobiological Understanding of Alcoholism
(12) Patent Application Publication (10) Pub. No.: US 2015/0202317 A1 Rau Et Al
L:\0901 with Peru\0901PHARMAPPX.Wpd
Activation of Trpv1 Channel Contributes to Serotonin-Induced Constriction of Mouse Facial Artery Bolu Zhou University of Vermont
I Regulations
Screening of Clinically Approved and Investigation Drugs As Potential
WO 2018/152334 Al 23 August 2018 (23.08.2018) W !P O PCT
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission R ICHARD A
Pharmaceutical Appendix to the Tariff Schedule 2
Triptans, 5-HT1B/1D Receptor Agonists in the Acute Treatment of Migraines
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Top View
Lasmiditan Mechanism of Action – Review of a Selective 5-HT1F Agonist David B
Phd Antonia Asimakopoulou.Pdf
5-HT Receptors and Their Ligands, Tocris Reviews No
Pharmaabkommen A1 E
Antimigraine Drug Avitriptan Is a Ligand and Agonist of Human Aryl Hydrocarbon Receptor That Induces CYP1A1 in Hepatic and Intestinal Cells
Known Bioactive Library: Tocriscreen Mini Library 2
Customs Tariff - Schedule Xxi - 1
Implication De La Sérotonine Et Des Récepteurs 5-HT2 Dans Le Remodelage Valvulaire Cardiaque Roland Fabrice Lawson
Bioactive Compound Library Plus (96-Well)
(12) United States Patent (10) Patent No.: US 8,288,372 B2 Hale Et Al
Success and Failure of Triptans Peer Tfelt-Hansen
5-HT Receptor Serotonin Receptor; 5-Hydroxytryptamine Receptor
WO 2017/065602 Al 20 April 2017 (20.04.2017) P O P C T
Annexe I - Substances Pharmaceutiques, Admises En Exonération Des Droits______
Donitriptan, a Unique High-Efficacy 5-HT1B/1D Agonist: Key Features and Acute Antimigraine Potential
2U11/12457U A2
Non-Interventional PASS Protocol
WO 2017/130141 Al 3 August 2017 (03.08.2017) P O P C T
Tepzz 5 58¥Zb T
Reference: WLI/100 28 March 2007
Drug Class Review on Triptans
615.19 WIL 12Th
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Supplementary Material
Drug Class Review on Triptans
Donitriptan Selectively Decreases Jugular Venous Oxygen Saturation In
WO 2011/012715 Al
WO 2017/063771 Al 20 April 2017 (20.04.2017) P O P C T
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
L:\0900\0900PHARMAPPX .Wpd
Migraine — Current Understanding and Treatment
WO 2017/040864 Al 9 March 2017 (09.03.2017) P O P C T